In addition, we analyzed the alteration of major immune cell types (CD4+, CD8+ T cells, B cells and NK cells) in 117 cancer patients and showed that lymphocytes were diminished in cancer patients who died from COVID-19. This evidence concerns the gene CD4 and COVID-19.